Pancreatic Cyst Articles & Analysis: Older
3 news found
Additionally, the Company will be launching Point2Glucose™—a new pancreatic cyst fluid tumor marker diagnostic test offering that requires a very low volume of cyst fluid (0.2ml). ...
Rarecells Inc., a leading Liquid Biopsy company is pleased to announce the development of an innovative and accurate targeted digital single-cell Next-Generation Sequencing (scNGS) for single-nucleotide variant (SNV) method to detect mutant genes of pancreatic ductal adenocarcinoma (PDAC) circulating tumor cells (CTC) enriched by the ISET® technology. ...
“The addition of advanced diagnostic techniques, such as nCLE, to standard cyst fluid chemistry and cytology should be considered when performing EUS-FNA of pancreatic cystic lesions.” “The characterization of pancreatic cysts remains a major medical challenge around the world, with more than 2.6% of the U.S. ...